header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FIG-090527-41
North et al., 2009 - Hematopoietic stem cell development is dependent on blood flow. Cell   137(4):736-748 Full text @ Cell
ADDITIONAL FIGURES
EXPRESSION / LABELING:
Genes:
Fish:
Conditions:
Anatomical Terms:
Stage: Prim-25

Fig. 3 NO Signaling prior to the Onset of Cardiac Activity can Affect HSC Formation

(A–G) Effect of vasoactive drugs (10 μM) on HSC formation before and after the onset of heartbeat at 24 hpf, after exposure to chemicals from either 10 somites–23 hpf or from 26–36 hpf.

(A) Most vasoactive drugs do not affect HSC formation when applied prior to the onset of heartbeat, while NO modifiers influenced HSC development even prior to heart beat initiation. The percentage of embryos (n > 20) with altered runx1/cmyb expression is indicated.

(B–G) Representative examples of flow-modifying drugs on runx1/cmyb expression.

(H–P) Specificity of NO signaling in HSC formation. NO donors enhanced and inhibitors diminished HSCs; inactive D-enantiomers had no effect.

(Q–S) Effects of NO modulation on HSC number by in vivo confocal imaging in cmyb:GFP; lmo2:dsRed transgenic embryos.

(T–Y) Effects of downstream modifiers of NO signaling on runx1/cmyb expression.

(U and X) Inhibition of soluble guanyl cyclase by ODQ (10 μM) decreases runx1/cmyb expression in WT and SNAP treated embryos.

(V and Y) Inhibition of PDE V by MBMQ (10 μM) increases HSC formation in WT embryos and further enhances the effects of SNAP.

Gene Expression Details
Gene Antibody Fish Conditions Stage Anatomy Assay
DsRed zf169Tg; zf73Tg control Prim-25 ventral wall of dorsal aorta IFL
zf169Tg; zf73Tg chemical treatment: pharmaceutical Prim-25 ventral wall of dorsal aorta IFL
zf169Tg; zf73Tg chemical treatment: S-nitroso-N-acetyl-D-penicillamine Prim-25 ventral wall of dorsal aorta IFL
EGFP zf169Tg; zf73Tg control Prim-25 vasculature IFL
zf169Tg; zf73Tg chemical treatment: pharmaceutical Prim-25 vasculature IFL
zf169Tg; zf73Tg chemical treatment: S-nitroso-N-acetyl-D-penicillamine Prim-25 vasculature IFL
myb WT control Prim-25 ventral wall of dorsal aorta hematopoietic stem cell ISH
WT chemical treatment: pharmaceutical Prim-25 ventral wall of dorsal aorta hematopoietic stem cell ISH
WT chemical treatment: S-nitroso-N-acetyl-D-penicillamine Prim-25 ventral wall of dorsal aorta hematopoietic stem cell ISH
runx1 WT control Prim-25 ventral wall of dorsal aorta hematopoietic stem cell ISH
WT standard conditions Prim-25 ventral wall of dorsal aorta hematopoietic stem cell ISH
WT chemical treatment: pharmaceutical Prim-25 ventral wall of dorsal aorta hematopoietic stem cell ISH
WT chemical treatment: S-nitroso-N-acetyl-D-penicillamine Prim-25 ventral wall of dorsal aorta hematopoietic stem cell ISH
Antibody Labeling Details No data available
Phenotype Details No data available
Acknowledgments:
ZFIN wishes to thank the journal Cell for permission to reproduce figures from this article. Please note that this material may be protected by copyright.

Reprinted from Cell, 137(4), North, T.E., Goessling, W., Peeters, M., Li, P., Ceol, C., Lord, A.M., Weber, G.J., Harris, J., Cutting, C.C., Huang, P., Dzierzak, E., and Zon, L.I., Hematopoietic stem cell development is dependent on blood flow, 736-748, Copyright (2009) with permission from Elsevier. Full text @ Cell